Search
NS-3728
go.drugbank.com/drugs/DB05835ExperimentalNS3728 is an orally active chloride channel blocker for the treatment of cancer.
EHC18
go.drugbank.com/drugs/DB05114ExperimentalEHC18 is an immune regulation medicine. It is a broad spectrum of specific HCV proteins.
Flunoxaprofen
go.drugbank.com/drugs/DB13317ExperimentalCategories: Analgesics, Non-Narcotic, Non COX-2 selective NSAIDSUrsolic acid
go.drugbank.com/drugs/DB15588InvestigationalCategories: Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-SteroidalEfinopegdutide
go.drugbank.com/drugs/DB15077InvestigationalEfinopegdutide is under investigation in clinical trial NCT03606057 (A Study to Investigate the Effect of JNJ-64565111 on Cardiac Repolarization (Corrected QT Interval) Compared With Placebo in Healthy
Osoresnontrine
go.drugbank.com/drugs/DB16274Investigationalin clinical trial NCT02281773 (A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on
Diacerein
go.drugbank.com/drugs/DB11994ApprovedInvestigationalWithdrawnDiacerein is a prodrug which is metabolized to rhein. It is currently approved in France for the treatment of osteoarthritis although the use of diacerein is restricted due to the side effects including severe diarrhea . Diacerein is und...
Categories: Antiinflammatory and Antirheumatic Products, Non-SteroidsPhenserine
go.drugbank.com/drugs/DB04892InvestigationalPhenserine is under development by Axonyx, a US biopharmaceutical company that focuses on treatments for dementia. … Axonyx announced on 20 September 2005 that phenserine was ineffective in two curtailed phase 3 trials.
Senlizumab
go.drugbank.com/drugs/DB17894ExperimentalCategories: Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-SteroidalSAR443122
go.drugbank.com/drugs/DB16492InvestigationalAdditionally, NCT04781816, which was completed with results, focused on patients with cutaneous lupus erythematosus.